74 related articles for article (PubMed ID: 1768559)
1. Clinical pharmacology of prochlorperazine in healthy young males.
Isah AO; Rawlins MD; Bateman DN
Br J Clin Pharmacol; 1991 Dec; 32(6):677-84. PubMed ID: 1768559
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and effects of prochlorperazine in elderly female volunteers.
Isah AO; Rawlins MD; Bateman DN
Age Ageing; 1992 Jan; 21(1):27-31. PubMed ID: 1553856
[TBL] [Abstract][Full Text] [Related]
3. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of azapropazone following single oral and intravenous doses.
Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route.
Finn A; Collins J; Voyksner R; Lindley C
J Clin Pharmacol; 2005 Dec; 45(12):1383-90. PubMed ID: 16291713
[TBL] [Abstract][Full Text] [Related]
6. Preliminary studies of the pharmacokinetics and pharmacodynamics of prochlorperazine in healthy volunteers.
Taylor WB; Bateman DN
Br J Clin Pharmacol; 1987 Feb; 23(2):137-42. PubMed ID: 3828192
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers.
Hijazi Y; Welker H; Dorr AE; Tang JP; Blain R; Renzetti LM; Abbas R
J Clin Pharmacol; 2004 Dec; 44(12):1368-78. PubMed ID: 15545307
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics and bioavailability of prochlorperazine delivered as a thermally generated aerosol in a single breath to volunteers.
Avram MJ; Spyker DA; Henthorn TK; Cassella JV
Clin Pharmacol Ther; 2009 Jan; 85(1):71-7. PubMed ID: 18830225
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
[TBL] [Abstract][Full Text] [Related]
11. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration to healthy volunteers.
Efthymiopoulos C; Strolin Benedetti M; Poggesi I; Ruff F; Basileo G; Musatti L
Therapie; 1993; 48(1):23-6. PubMed ID: 8356541
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing.
Chu KM; Shieh SM; Hu OY
Clin Pharmacol Ther; 1995 Jun; 57(6):610-21. PubMed ID: 7781260
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
Bohlooli S; Keyhanfar F; Mahmoudian M
Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig.
Goyarts T; Dänicke S
Toxicol Lett; 2006 Jun; 163(3):171-82. PubMed ID: 16326049
[TBL] [Abstract][Full Text] [Related]
18. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
Goren MP; Houle JM; Bush DA; Li JT; Newman CE; Brade WP
Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960
[TBL] [Abstract][Full Text] [Related]
19. Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker.
Sridhar KS; Krishan A; Samy TS; Duncan RC; Sauerteig A; McPhee GV; Auguste ME; Benedetto PW
Cancer Chemother Pharmacol; 1994; 34(5):377-84. PubMed ID: 8070004
[TBL] [Abstract][Full Text] [Related]
20. Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies.
Sridhar KS; Krishan A; Samy TS; Sauerteig A; Wellham LL; McPhee G; Duncan RC; Anac SY; Ardalan B; Benedetto PW
Cancer Chemother Pharmacol; 1993; 31(6):423-30. PubMed ID: 8453681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
